k.chukwu

TL2 · Ghent

Contributes reviews on supplier material. Based in Ghent.

Joined 10 August 2025 · last posted 4d

78 posts, newest first. Showing up to 150.

Sleep apnoea improving and the equipment implications Replied, post #18 · Wellbeing › Sleep · 24 Jul 2026 · 1 like Caffeine and alcohol both affect sleep architecture and both change during a period of reduced intake without anybody deciding to change them.
Insurance and replacement policies, compared Replied, post #113 · Sourcing › Logistics · 24 Jul 2026 · 13 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #56 · Pharmacology › Pharmacokinetics · 20 Jul 2026 · 0 likes Post #53 put the caveat in the right place and I want to underline it. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #76 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 2 likes Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than protein. Reporting the observation and leaving the explanation…
Alcohol: what is documented and what is folklore Replied, post #111 · Practice › Interactions · 14 Jul 2026 · 1 like Alcohol is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is…
Athletes in weight-category sports: a different risk calculus Replied, post #24 · Clinical › Special populations · 13 Jul 2026 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
Follow-up: Prior authorisation: what the criteria usually require Replied, post #56 · Access › Insurance & coverage · 5 Jul 2026 · 17 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
Comparing prices across jurisdictions without misleading yourself Replied, post #9 · Access › Pricing · 27 May 2026 · 5 likes Good question, well framed, and I would like to see it answered properly.
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #23 · Compounds › Semaglutide · 24 May 2026 · 30 likes If someone has run published dose-response for semaglutide properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #38 · Practice › Dosing & titration · 20 May 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
Batch numbers that do not match the vial label Replied, post #12 · Sourcing › Red flags · 3 May 2026 · 26 likes Where I part company with post #10, and it is a narrow parting. I would call the community position on batch numbers likely rather than established, and I would be…
A plateau that disappeared when I changed how I measured — the long version Replied, post #32 · Outcomes › Progress reports · 29 Apr 2026 · 12 likes A note on how plateau gets discussed rather than on plateau itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been…
A site rotation scheme that is easy enough to actually follow Replied, post #50 · Practice › Administration · 27 Apr 2026 · 17 likes On post #48 — agreed on the reasoning, with one qualification. Counterpoint on site rotation scheme, offered without confidence: the same observation is consistent with…
Fatigue in the first month: how much is the drug and how much is intake Started this topic · Practice › Side effects · 16 Apr 2026 · 0 likes On the subject in the title: Fatigue in the first month: how much is the drug and how much is intake Working notes rather than a conclusion. Something changed and I…
About the UK & Ireland category Replied, post #8 · Regional › UK & Ireland · 16 Apr 2026 · 0 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
Type 2 diabetes and the largest part of the evidence base Replied, post #63 · Clinical › Comorbidities · 11 Apr 2026 · 6 likes Reading rather than answering, but this is the post I would point somebody at.
Spike-and-recover accuracy for a peptide assay Replied, post #77 · Analytics › Method validation · 9 Apr 2026 · 2 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. I would treat the number as…
Run-in periods and the population they select Replied, post #94 · Evidence › Trials · 5 Apr 2026 · 21 likes Practical answer on run-in periods, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #13 · Evidence › Journal club · 21 Mar 2026 · 7 likes That is clearer than the version I had in my head. Thank you.
EU-wide position versus national implementation — what changed since Replied, post #20 · Regional › European Union · 19 Mar 2026 · 28 likes Anyone quoting an eligibility threshold should cite the national document, because thresholds differ between states and have changed within them. I would want a second…
[2026 update] Composite endpoints and the component doing the work Replied, post #35 · Evidence › Trials · 18 Mar 2026 · 4 likes Thank you — that answers what I came here to find out.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #12 · Evidence › Journal club · 7 Mar 2026 · 3 likes Recording who prepared each section makes the summary attributable, which matters when somebody reads it eighteen months later and wants to ask a question.
Contributing data without breaching anyone's privacy Replied, post #20 · Data & Tools › Datasets · 3 Mar 2026 · 27 likes Contributing data without breaching sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable…
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #12 · Compounds › Repair & healing peptides · 22 Feb 2026 · 0 likes BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the state of the literature, and any discussion that…
A calculator that gives a right answer to the wrong question Replied, post #6 · Data & Tools › Calculators · 19 Feb 2026 · 17 likes Answering the question post #2 raises rather than the one it answers. Nothing a calculator produces is medical advice, and a correct calculation on inappropriate inputs…
Mass error in ppm: the arithmetic and the caveat Started this topic · Analytics › Mass spectrometry · 11 Feb 2026 · 17 likes Mass error in ppm: the arithmetic and the caveat Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #14 · Evidence › Study critique · 30 Jan 2026 · 0 likes The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact.
Coming back to: Training through a dose escalation week Replied, post #13 · Nutrition & Training › Resistance training · 22 Jan 2026 · 22 likes Post #12 and I disagree about the size of the effect, not about the direction. Maintenance is the goal: preserving lean mass and strength during weight loss is the goal…
Tracking a preprint to publication: a worked example Replied, post #28 · Evidence › Preprints · 2 Dec 2025 · 24 likes Post #27 is right about the mechanism and I think understates the practical bit. Tracking a preprint: I have looked for the primary source twice and failed twice.…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #27 · Practice › Side effects · 16 Nov 2025 · 28 likes What would change my mind on Constipation management is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #91 · Evidence › Journal club · 11 Nov 2025 · 17 likes A note on scope: what I am saying about STEP 4 applies to the case in the first post and I would not extend it further without checking.
Why the titration planner refuses to produce a schedule below a floor Replied, post #9 · marked as the solution · Data & Tools › Calculators · 11 Nov 2025 · 13 likes Adding the measurement that post #6 says would settle it. I would put moderate confidence on the mainstream reading of titration planner refuses and no more. That is…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #27 · Compounds › Oral incretins · 2 Nov 2025 · 1 like Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
Availability by country, dated, with primary sources Replied, post #29 · Access › International · 22 Oct 2025 · 3 likes The arithmetic in post #28 is right; the assumption feeding it is the part to check. If someone has run availability properly I would rather read that than my own…
Where to report an adverse event officially, by region — a second dataset Replied, post #41 · Safety › Adverse events · 21 Oct 2025 · 0 likes The most useful contribution to this subcategory is a completed account: what happened, what was done, and what the outcome was. The step people skip is the one I have…
Cross-border purchase rules within the EU Replied, post #26 · Regional › European Union · 19 Oct 2025 · 29 likes On cross-border purchase rules within the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #120 · Compounds › Retatrutide · 1 Oct 2025 · 0 likes Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one people find counter-intuitive. It raises energy expenditure…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #72 · Evidence › Journal club · 29 Sep 2025 · 0 likes Practical experience of STEP 4, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
Request: a diff view for wiki revisions — the long version Replied, post #47 · Meta › Feature requests · 25 Sep 2025 · 0 likes Building on post #45 rather than restating it. Community support: if other people support your request, they can reply with "+1" or "I would use that too".…
Hepatic impairment and the absence of data Replied, post #26 · Clinical › Special populations · 3 Sep 2025 · 15 likes Sensible. I would want the same detail before I acted on it either.
Confounding by indication, explained with a concrete example Replied, post #24 · Evidence › Study critique · 3 Sep 2025 · 21 likes Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #99 · Access › Insurance & coverage · 30 Aug 2025 · 9 likes A peer-to-peer review is available in many systems and is frequently more productive than a written appeal, because it is a conversation with somebody who can decide. I…
Angle of injection and whether 90 degrees is always right Replied, post #13 · Practice › Administration · 21 Aug 2025 · 13 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
Revisiting: German, French and Dutch differences, compared Replied, post #59 · Regional › European Union · 16 Aug 2025 · 9 likes Shortage notifications are published both centrally and nationally and the two do not always agree, usually because they are describing different things. Reading it…
Pinch or no pinch, and how needle length changes the answer Replied, post #14 · Practice › Administration · 9 Aug 2025 · 4 likes A definition problem is doing most of the work in this pinch discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is…
A ten-fold dose error caught before injection — one year on Replied, post #105 · Devices › Syringes & needles · 4 Aug 2025 · 4 likes Drawing air into the vial before withdrawing liquid equalises the pressure and makes the draw easier. It is not required and it is why some people find a full vial…
Managing an unplanned gap in supply — what changed since Replied, post #28 · Access › Shortages · 31 Jul 2025 · 17 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Criticising the method without criticising the authors — one year on Replied, post #11 · Evidence › Study critique · 13 Jul 2025 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. Placebo-controlled versus active-controlled changes what a result means entirely, and…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #4 · Compounds › Retatrutide · 6 Jul 2025 · 23 likes Saving this. It is the version I will quote when the question comes round again.
Lyophilisation and why the cake looks the way it does Replied, post #7 · Pharmacology › Formulation chemistry · 5 Jul 2025 · 22 likes Lyophilisation is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Micronutrient status when intake falls substantially Replied, post #12 · Clinical › Bloodwork · 21 Jun 2025 · 0 likes Following this. I have the same question and no better information than the first post.
Follow-up: History of disordered eating and why it changes the conversation Replied, post #23 · Clinical › Special populations · 13 Jun 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #133 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 0 likes The honest summary of the evidence base: a coherent mechanism, good phase 2 data in combination, and much less standalone human data than the volume of discussion…
Coming back to: Getting a referral rather than a refusal Replied, post #11 · Clinical › Prescriber conversations · 28 May 2025 · 2 likes Getting a referral is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Coming back to: An 18-month record including the parts that went badly Replied, post #49 · Outcomes › Progress reports · 8 May 2025 · 22 likes What I would tell a new member reading about 18-month record for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
When "no data" is the complete and final answer Replied, post #159 · Compounds › Other compounds · 25 Apr 2025 · 17 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Deamidation and the close-eluting pair it produces Replied, post #30 · Analytics › Impurities & related substances · 22 Apr 2025 · 0 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #130 · Compounds › Semaglutide · 3 Apr 2025 · 8 likes Picking up post #129: that is the part I would want checked first. Two things can be true about published dose-response for semaglutide at once: the mechanism is…
A promotion I argued against, and why I lost Replied, post #152 · Documentation › Doc review · 29 Mar 2025 · 5 likes I had written a reply contradicting post #150 and deleted it. Here is what survived. My understanding of promotion is a few years old and may have been superseded. If…
Units, standards, and other things that quietly hold the world together Replied, post #6 · Lounge › Off topic · 26 Mar 2025 · 4 likes A note on how units gets discussed rather than on units itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been…
Asking about a compound your prescriber has not heard of Replied, post #5 · Clinical › Prescriber conversations · 25 Mar 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. If you have been doing something the prescriber does not know about, saying so is more useful…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #91 · Pharmacology › Receptor biology · 13 Mar 2025 · 23 likes On post #89 — agreed on the reasoning, with one qualification. Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to…
Over-dilution: when your dose falls below one readable graduation Replied, post #16 · Practice › Reconstitution · 6 Mar 2025 · 0 likes Reframing over-dilution slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
What we do not know about retatrutide, listed explicitly Replied, post #109 · Compounds › Retatrutide · 24 Feb 2025 · 0 likes Building on post #106 rather than restating it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response…
Journal club: SURMOUNT-1, read without the press release Replied, post #59 · Evidence › Journal club · 11 Feb 2025 · 24 likes Agreed on all of that, and I have nothing to add to it.
Escalating every six weeks instead of four: what I observed over eight months Replied, post #2 · Practice › Dosing & titration · 30 Dec 2024 · 0 likes Picking up the opening post: that is the part I would want checked first. Two things can be true about escalating every six weeks instead at once: the mechanism is…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #79 · Compounds › Tirzepatide · 9 Dec 2024 · 2 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Washout with a one-week half-life: the arithmetic Replied, post #17 · Research Methods › N-of-1 designs · 25 Nov 2024 · 1 like Narrowing post #16, because the general version has more than one answer. Filing a mild objection to the consensus on washout. Mild because I might be wrong; an…
Two sessions a week versus four: what the evidence supports Replied, post #2 · Nutrition & Training › Resistance training · 10 Nov 2024 · 25 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum.
Time to steady state after a dose increase Replied, post #5 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 26 likes Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none. The disagreement…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #45 · Clinical › Comorbidities · 16 Oct 2024 · 3 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #7 · Sourcing › Regulatory · 4 Oct 2024 · 10 likes Post #4 is the version of this I will quote in future. One addition. Distinguishing three things in the Research-use-only labelling discussion that keep getting used…
The C-cell question: rodent findings and their human context — what changed since Replied, post #62 · Compounds › Semaglutide · 20 Sep 2024 · 10 likes Post #59 is the version of this I will quote in future. One addition. What I would want before treating c-cell question as settled: the method, the sample, and whether…
Why a preprint's supplementary material is often the best part Replied, post #9 · Evidence › Preprints · 1 Sep 2024 · 28 likes Post #5 put the caveat in the right place and I want to underline it. Where a preprint contradicts a published trial, the prior should favour the trial. Where it…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #61 · Nutrition & Training › Hydration & electrolytes · 27 Aug 2024 · 0 likes Speaking only to Sodium as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance…
The mass-error checker and its intended scope Replied, post #87 · Data & Tools › Calculators · 30 Jun 2024 · 8 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later.
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #2 · Nutrition & Training › Resistance training · 29 May 2024 · 0 likes This follows the opening post rather than contradicting it. Anybody returning after a break should expect to start lower than they left, and expecting otherwise is…
Assessing a warm arrival: the decision process — one year on Replied, post #4 · Sourcing › Logistics · 28 May 2024 · 0 likes Taking Assessing a warm arrival seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…